Cosmos Health Statistics
Total Valuation
Cosmos Health has a market cap or net worth of $20.34 million. The enterprise value is $38.64 million.
Important Dates
The last earnings date was Monday, August 18, 2025.
| Earnings Date | Aug 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cosmos Health has 30.21 million shares outstanding. The number of shares has increased by 60.93% in one year.
| Current Share Class | 30.21M |
| Shares Outstanding | 30.21M |
| Shares Change (YoY) | +60.93% |
| Shares Change (QoQ) | +10.43% |
| Owned by Insiders (%) | 28.16% |
| Owned by Institutions (%) | 3.33% |
| Float | 20.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | 0.66 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 1.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.98 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.61 |
Financial Efficiency
Return on equity (ROE) is -52.69% and return on invested capital (ROIC) is -20.97%.
| Return on Equity (ROE) | -52.69% |
| Return on Assets (ROA) | -14.67% |
| Return on Invested Capital (ROIC) | -20.97% |
| Return on Capital Employed (ROCE) | -46.93% |
| Revenue Per Employee | $369,755 |
| Profits Per Employee | -$144,744 |
| Employee Count | 149 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 6.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.82% in the last 52 weeks. The beta is 4.17, so Cosmos Health's price volatility has been higher than the market average.
| Beta (5Y) | 4.17 |
| 52-Week Price Change | -39.82% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 0.59 |
| Relative Strength Index (RSI) | 41.70 |
| Average Volume (20 Days) | 574,006 |
Short Selling Information
The latest short interest is 700,284, so 2.32% of the outstanding shares have been sold short.
| Short Interest | 700,284 |
| Short Previous Month | 749,359 |
| Short % of Shares Out | 2.32% |
| Short % of Float | 3.48% |
| Short Ratio (days to cover) | 0.51 |
Income Statement
In the last 12 months, Cosmos Health had revenue of $55.09 million and -$21.57 million in losses. Loss per share was -$0.89.
| Revenue | 55.09M |
| Gross Profit | 5.42M |
| Operating Income | -14.39M |
| Pretax Income | -18.54M |
| Net Income | -21.57M |
| EBITDA | -13.12M |
| EBIT | -14.39M |
| Loss Per Share | -$0.89 |
Full Income StatementBalance Sheet
The company has $685,769 in cash and $15.65 million in debt, giving a net cash position of -$14.96 million or -$0.50 per share.
| Cash & Cash Equivalents | 685,769 |
| Total Debt | 15.65M |
| Net Cash | -14.96M |
| Net Cash Per Share | -$0.50 |
| Equity (Book Value) | 26.23M |
| Book Value Per Share | 0.88 |
| Working Capital | -604,250 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.49 million and capital expenditures -$336,313, giving a free cash flow of -$4.83 million.
| Operating Cash Flow | -4.49M |
| Capital Expenditures | -336,313 |
| Free Cash Flow | -4.83M |
| FCF Per Share | -$0.16 |
Full Cash Flow StatementMargins
Gross margin is 9.85%, with operating and profit margins of -26.13% and -27.90%.
| Gross Margin | 9.85% |
| Operating Margin | -26.13% |
| Pretax Margin | -27.90% |
| Profit Margin | -27.90% |
| EBITDA Margin | -23.82% |
| EBIT Margin | -26.13% |
| FCF Margin | n/a |
Dividends & Yields
Cosmos Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.93% |
| Shareholder Yield | -60.93% |
| Earnings Yield | -91.09% |
| FCF Yield | -20.39% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 16, 2022. It was a reverse split with a ratio of 1:25.
| Last Split Date | Dec 16, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
Cosmos Health has an Altman Z-Score of -2.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.3 |
| Piotroski F-Score | 4 |
